The MADO study of the need, reasons and strategies for dose adjustment in allergen immunotherapy: patient profiles

被引：0
|
作者：
Thetis-Soulie, M. [1 ]
Hosotte, M. [2 ]
Grozelier, I [3 ]
Baillez, C. [4 ]
Scurati, S. [5 ]
Mercier, V [6 ]
机构：
[1] Private Practice, Creteil, France
[2] Gentilly Allergy Ctr, Nancy, France
[3] Private Practice, Cholet, France
[4] Private Practice, Perpignan, France
[5] Stallergenes Greer, Med Affairs, Antony, France
[6] Private Practice, Toulouse, France
来源：
ALLERGY | 2021年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
269
引用
收藏
页码：41 / 41
页数：1
相关论文
共 43 条
  • [11] Analysis of treatment regimens in the PRACTIS study : an observational, prospective, longitudinal study of the patient profiles and the treatment benefits of sublingual allergen immunotherapy
    Demoly, P.
    Bosse, I
    Chabane, H.
    Scurati, S.
    ALLERGY, 2021, 76 : 47 - 47
  • [12] Systemic Reactions in Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy with and without Seasonal Dose Adjustment
    Albuhairi, Sultan
    Sare, Tatyana
    Lakin, Paul
    El Khoury, Kristel
    Crestani, Elena
    Schneider, Lynda C.
    Anzaldi, Rocco
    Patterson, Al
    Rachid, Rima
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (05): : 1711 - +
  • [13] The population's baseline characteristics in the PRACTIS study: an observational, prospective, longitudinal study of patient profiles and treatment benefits of sublingual allergen immunotherapy
    Demoly, P.
    Chabane, H.
    Bosse, I
    Scurati, S.
    ALLERGY, 2021, 76 : 52 - 52
  • [14] The Rate of Systemic Reactions In Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy Is Elevated and Not Affected by Seasonal Dose Adjustment
    Albuhairi, Sultan
    Sare, Tatyana
    Lakin, Paul
    El Khoury, Kristel
    Crestani, Elena
    Schneider, Lynda C.
    Anzaldi, Rocco
    Paterson, Al
    Rachid, Rima A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB191 - AB191
  • [15] Dose Adjustment After Gaps in Administration of Subcutaneous Immunotherapy From a Past Survey: Work Group Report of the AAAAI Allergen Standardization and Allergy Diagnostics Committee
    Larenas-Linnemann, Desiree
    Ponda, Punita
    Creticos, Peter
    Bernstein, David
    Epstein, Tolly
    Williams, Paul
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (01): : 145 - +
  • [16] Design of a phase II allergen immunotherapy study to determine the optimally effective and safe dose of subcutaneously administered tyrosine adsorbed modified grass allergen plus MPL
    Zielen, S.
    Kuna, P.
    Aberer, W.
    Lassmann, S.
    Wade, A.
    Kluehr, K.
    Raab, J.
    Lee, D.
    Ballard, R.
    Jones, C.
    Gunawardena, K.
    Skinner, M. A.
    Higenbottam, T.
    ALLERGY, 2018, 73 : 487 - 488
  • [17] Examining the need profiles of patients with multiple emergency department visits for mental health reasons: a cross-sectional study
    Sirotich, Frank
    Durbin, Anna
    Durbin, Janet
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2016, 51 (05) : 777 - 786
  • [18] Examining the need profiles of patients with multiple emergency department visits for mental health reasons: a cross-sectional study
    Frank Sirotich
    Anna Durbin
    Janet Durbin
    Social Psychiatry and Psychiatric Epidemiology, 2016, 51 : 777 - 786
  • [19] Strong Dose-response On Immunoglobulin Makers During a Phase II Allergen Immunotherapy Study With Subcutaneously Administered Tyrosine Adsorbed Modified Grass Allergen plus MPL
    Lassmann, Sabine
    Lee, Denise
    Zielen, Stefan
    Aberer, Werner
    Wade, Anette
    Kluehr, Karolin
    Raab, Jennifer
    Ballard, Rachel
    Jones, Chris
    Gunawardena, Kulasari
    Kramer, Matthias
    Skinner, Murray A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB306 - AB306
  • [20] Strong dose-response on immunoglobulin markers during a phase II allergen immunotherapy study with subcutaneously administered tyrosine adsorbed modified grass allergen plus MPL
    Zielen, S.
    Aberer, W.
    Lassmann, S.
    Wade, A.
    Kluehr, K.
    Raab, J.
    Lee, D.
    Ballard, R.
    Jones, C.
    Gunawardena, K.
    Kramer, M. F.
    Skinner, M. A.
    Hingebottam, T.
    De Kam, P.
    ALLERGY, 2019, 74 : 686 - 686
12345